Amino Acids Market size stood at USD 34.6 billion in 2026 and is predicted to grow at a 7.32% CAGR from 2027 to 2036, surpassing USD 70.13 billion by 2036. The industry revenue for 2027 is calculated at USD 36.73 billion.
Rising consumer interest in health and wellness is increasing nutraceutical consumption, supporting amino acids market growth through greater use of amino acids in dietary supplements. Their role as functional nutritional ingredients makes them relevant to supplement formulations designed to address evolving consumer preferences for targeted nutritional support.
Broader use of amino acids in animal feed and pet nutrition is strengthening demand across applications where nutritional composition is an important consideration. The amino acids market is benefiting as feed and pet food formulations increasingly incorporate these ingredients to support balanced nutrition and formulation requirements.
Increasing incorporation of functional ingredients into skincare and cosmetic products is creating an additional application pathway for amino acids. In particular, amino acids market demand is supported by their use in formulations where functional properties can complement product development focused on skin care and cosmetic performance.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising nutraceutical consumption driving amino acids demand in dietary supplements | 2.00% | Moderate | Asia Pacific, Europe | High | Near Term |
| Expanding animal feed and pet nutrition applications strengthening amino acid utilization | 1.70% | Low | Asia Pacific, North America | High | Mid Term |
| Growth in skincare and cosmetic formulations incorporating functional amino acid ingredients | 1.50% | Moderate | Europe, North America | Medium | Mid Term |
The amino acids market in Asia Pacific represented a 49.61% share in 2026, supported by the region's extensive food processing, animal nutrition, pharmaceutical, and dietary supplement industries. Growing demand for protein-enriched foods and functional nutrition is encouraging broader use of amino acids as nutritional and formulation ingredients. The region's large consumer base, expanding healthcare expenditure, and increasing awareness of nutritional wellness are also strengthening demand. In addition, well-established manufacturing capabilities for food ingredients and pharmaceuticals, combined with expanding production capacity across emerging economies, provide a strong foundation for regional market leadership.
North America is experiencing the fastest growth in the amino acids market, driven by rising consumer interest in sports nutrition, functional foods, dietary supplementation, and health-oriented formulations. Growing emphasis on preventive wellness and personalized nutrition is encouraging manufacturers to incorporate specialized amino acids into products targeting specific nutritional needs. The region's advanced food and pharmaceutical processing infrastructure also facilitates innovation in ingredient formulations and delivery formats. Strong research activity and increasing demand for clean-label and performance-oriented nutrition products are further creating opportunities for amino acid applications across food, healthcare, and wellness categories.
The U.S. amino acids market is supported by strong demand from dietary supplements, sports nutrition, and pharmaceutical formulations. Manufacturers in the U.S. continue to invest in specialty amino acid applications that address functional health and personalized nutrition trends.
Japan's amino acids market is characterized by extensive use in functional foods, medical nutrition, and health-focused consumer products. Japanese companies continue to develop value-added amino acid formulations tailored to wellness and aging-related applications.
South Korea is expanding the use of amino acids in cosmetics, nutritional supplements, and functional beverages. Market participants in South Korea are increasingly focusing on differentiated formulations and premium ingredient positioning to meet health-conscious consumer preferences.
Germany emphasizes amino acid production and application in pharmaceuticals, animal nutrition, and industrial biotechnology. The German market benefits from advanced manufacturing capabilities and increasing interest in fermentation-derived specialty ingredients.
France demonstrates steady demand for amino acids in clinical nutrition, sports supplementation, and premium food ingredients. The French market is increasingly incorporating amino acids into wellness-oriented product development and specialized dietary formulations.
Italy's amino acids market is supported by applications in animal feed and nutritional products targeting health and performance benefits. Italian manufacturers and ingredient suppliers are increasingly emphasizing high-quality formulations for food and feed industries.
In the amino acids market, non-essential amino acids represented the largest segment with a 55.02% share in 2026. Their broad application across food and beverage, animal nutrition, pharmaceuticals, and other industrial uses supports substantial demand. These amino acids are important in nutritional formulations and biological processes, while their versatility allows manufacturers to incorporate them into a wide range of products. Increasing attention to nutritional quality and functional ingredients is further supporting their continued utilization across multiple end-use industries.
Essential amino acids are the fastest-growing product segment, benefiting from increasing awareness of their importance in nutrition and their inability to be produced naturally by the human body. Demand is being supported by expanding interest in protein-enriched foods, dietary nutrition, sports-oriented formulations, and specialized nutritional products. The growing focus on targeted nutritional supplementation is encouraging manufacturers to develop formulations containing specific essential amino acid profiles, creating additional opportunities for segment expansion.
Plant-based sources held the largest position in the amino acids market, accounting for a 46.85% share in 2026. Their established availability and suitability for nutritional and food-related applications support widespread utilization. Increasing consumer preference for plant-derived ingredients and growing interest in sustainable sourcing are also strengthening the role of plant-based amino acids. In addition, their compatibility with clean-label and plant-oriented product formulations is encouraging adoption among manufacturers responding to evolving dietary preferences.
Fermentation is emerging as the fastest-growing source segment as producers increasingly seek efficient and scalable methods for obtaining high-quality amino acids. Fermentation-based production can support consistent product characteristics while reducing dependence on conventional extraction approaches. Growing demand for specialized amino acid formulations, coupled with advances in biotechnology and sustainable manufacturing practices, is creating favorable conditions for greater use of fermentation-derived amino acids across food, nutrition, pharmaceutical, and industrial applications.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| Product | Essential, Non-essential | Non-essential | Essential |
| Source | Plant-based, Animal-based, Chemical Synthesis, Fermentation | Plant-based | Fermentation |
| Grade | Food Grade, Feed Grade, Pharma Grade, Others | Pharma Grade | Feed Grade |
| End Use | Food & Beverage, Animal Feed, Pet Food, Pharmaceuticals, Vaccine Formulation, Personal Care & Cosmetics, Dietary Supplements, Agriculture, Others | Food & Beverage | Personal Care & Cosmetics |
1. Ajinomoto Co. Inc. (Japan)
2. Archer Daniels Midland Company (United States)
3. CJ CheilJedang Corporation (South Korea)
4. Evonik Industries AG (Germany)
5. dsm-firmenich AG (Switzerland)
6. Meihua Holdings Group Co. Ltd. (China)
7. Daesang Corporation (South Korea)
8. Dacheng Biochemical Technology Group Co. Ltd. (China)
9. Wacker Chemie AG (Germany)
10. Novus International Inc. (United States)
The amino acids market is experiencing steady expansion driven by growing utilization across nutrition, pharmaceuticals, and animal feed applications. Shifting dietary and health preferences are influencing formulation improvements. The amino acids market is also benefiting from ongoing research efforts aimed at enhancing bioavailability and production efficiency for specialized applications.
| Company Name | Date | Key Development |
|---|---|---|
| Daesang | Dec-24 | Daesang acquired German manufacturer Amino GmbH for approximately 50.2 billion won ($34 million). This strategic move facilitates Daesang’s entry into the pharmaceutical biotechnology segment, strengthening its industrial amino acid production capabilities and expanding its market footprint across Europe and high-value life sciences sectors. |
| FrieslandCampina Ingredients | Dec-24 | FrieslandCampina Ingredients acquired Wisconsin Whey Protein to bolster its North American manufacturing capacity for whey protein isolate. The integration of this production asset into its global network—spanning Europe, Asia, and North America—significantly expands output to meet rising international demand for high-quality protein and amino acid-based ingredients. |
| Verley | Dec-24 | Verley secured €32 million in Series A funding to accelerate the commercialization of its animal-free whey protein produced via fermentation. This capital injection is earmarked for scaling manufacturing infrastructure, enabling the company to bring its sustainable, alternative protein ingredients to market and challenge traditional supply chains in the amino acid-rich nutrition sector. |
| Evonik | Oct-24 | Evonik announced a major restructuring of its Health Care division, focusing on core growth areas like lipids and drug delivery. The company plans to discontinue pharmaceutical keto acid production in Hanau by late 2025 and is evaluating strategic divestment or partnership options for its amino acid manufacturing sites in Ham, France, and Wuming, China. |
| Arla Foods Ingredients | Nov-24 | Arla Foods Ingredients entered a strategic partnership with Valley Queen to enhance dairy-based ingredient production in the United States. The collaboration strengthens the company’s manufacturing base and supply chain resilience, improving its capacity to provide premium protein and amino acid solutions to the global food and nutrition markets. |
| Kyowa Hakko Bio | Nov-24 | Kyowa Hakko Bio completed an expansion of its citicoline production facility, significantly increasing manufacturing capacity. This investment supports the scaling of the company’s amino acid-derived bioactive ingredient portfolio and strengthens its strategic positioning within the high-growth functional nutrition and pharmaceutical ingredient markets. |
| Orffa | Dec-24 | Orffa launched Elovital, a specialized product line combining amino acids and vitamins, targeting the South Asian animal nutrition market. This initiative expands the company's regional portfolio with a standardized, integrated feed solution designed to enhance livestock nutritional performance and optimize nutrient utilization through precise amino acid supplementation. |
| Ingredion | Dec-24 | Ingredion launched an innovation initiative in collaboration with AI-focused partners Shiru and Holobiome. The partnership utilizes artificial intelligence to accelerate the discovery and development of functional ingredients, including amino acids and bioactive compounds, aimed at supporting gut health and enhancing the company's competitive R&D pipeline in nutrition. |
| Nutrabolt | Nov-24 | Nutrabolt acquired a 20% stake in Bloom Nutrition to expand its presence into the greens and superfood supplement segments. This investment diversifies Nutrabolt’s portfolio beyond core performance nutrition, strengthening its competitive position in functional wellness and dietary markets where amino acid-based and plant-derived supplements remain a key focus. |